Immunotherapy: Open Access : Citations & Metrics Report
Articles published in Immunotherapy: Open Access have been cited by esteemed scholars and scientists all around the world. Immunotherapy: Open Access has got h-index 9, which means every article in Immunotherapy: Open Access has got 9 average citations.
Following are the list of articles that have cited the articles published in Immunotherapy: Open Access.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
17 | 32 | 30 | 32 | 11 | 4 | 5 | 15 | 30 | 7 |
Research, Review articles and Editorials |
6 | 11 | 18 | 15 | 9 | 3 | 5 | 9 | 18 | 4 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
7 | 29 | 12 | 11 | 1 | 0 | 0 | 6 | 11 | 2 |
Conference proceedings |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 36 | 45 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
79 | 86 | 180 | 247 | 248 | 44 | 48 | 52 | 18 | 8 |
| Journal total citations count | 1028 |
| Journal impact factor | 0.77 |
| Journal 5 years impact factor | 1.13 |
| Journal cite score | 1.32 |
| Journal h-index | 9 |
| Journal h-index since 2019 | 7 |
Important citations (68)
Targeted delivery of il-12 adjuvants immunotherapy by oncolytic viruses |
|
Delivery of cancer therapies by synthetic and bio-inspired nanovectors |
|
Cytokines in oncolytic virotherapy |
|
Oncolytic virus encoding a master pro-inflammatory cytokine interleukin 12 in cancer immunotherapy |
|
Design, synthesis and biological activity of peptide vectors for cancer targeting and / or therapy |
|
Monoklonini? ir rekombinantini? antik?n? prieš karboanhidrazes k?rimas |
|
Imaging in tumor immunology |
|
Targeting the ether-à-go-go ion channels in cancer therapy: current knowledge and future perspectives |
|
Targeting and pharmacology of an anti-il13r?2 antibody and antibody-drug conjugate in a melanoma xenograft model |
|
Say no to drugs: bioactive macromolecular therapeutics without conventional drugs |
|
Conservation of oncofetal antigens on human embryonic stem cells enables discovery of monoclonal antibodies against cancer |
|
Cytokine?induced killer cells/natural killer cells combined with anti?gd2 monoclonal antibody increase cell death rate in neuroblastoma sk?n?sh cells |
|
Opportunities for antibody discovery using human pluripotent stem cells: conservation of oncofetal targets |
|
Targeting tumor vascular cd99 inhibits tumor growth |
|
In vivo imaging technologies to monitor the immune system |
|
Cd-340 functionalized doxorubicin-loaded nanoparticle induces apoptosis and reduces tumor volume along with drug-related cardiotoxicity in mice |
|
Targeting tumor vascular cd99 inhibits tumor growth |
|
Concepts for agonistic targeting of cd40 in immuno-oncology |
|
Retargeting lentiviruses via spycatcher-spytag chemistry for gene delivery into specific cell types |
|
Retargeting lentiviruses via spycatcher-spytag chemistry for gene delivery into specific cell types |
|